Maximus, Inc. $MMS Shares Sold by Reinhart Partners LLC.

Reinhart Partners LLC. trimmed its stake in shares of Maximus, Inc. (NYSE:MMS) by 4.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,901,996 shares of the health services provider’s stock after selling 80,419 shares during the quarter. Maximus makes up about 2.5% of Reinhart Partners LLC.’s portfolio, making the stock its 15th biggest position. Reinhart Partners LLC.’s holdings in Maximus were worth $101,167,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of MMS. BlackRock Inc. purchased a new position in Maximus in the 2nd quarter worth about $400,186,000. Dimensional Fund Advisors LP boosted its holdings in shares of Maximus by 7.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock worth $135,084,000 after buying an additional 141,362 shares during the period. Van Berkom & Associates Inc. boosted its holdings in shares of Maximus by 3.7% in the first quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider’s stock worth $75,137,000 after buying an additional 41,862 shares during the period. River Road Asset Management LLC increased its position in shares of Maximus by 236.1% in the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after acquiring an additional 578,326 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Maximus in the second quarter worth approximately $31,487,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insiders Place Their Bets

In other Maximus news, insider Michelle Link sold 3,208 shares of the stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total value of $173,969.84. Following the completion of the sale, the insider owned 13,881 shares in the company, valued at $752,766.63. This represents a 18.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Maximus Trading Up 1.0%

Shares of NYSE MMS opened at $59.37 on Friday. Maximus, Inc. has a one year low of $51.04 and a one year high of $100.00. The firm has a market capitalization of $3.11 billion, a PE ratio of 8.77 and a beta of 0.59. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90. The business has a 50-day moving average price of $56.81 and a two-hundred day moving average price of $59.82.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%. The firm’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, analysts predict that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.2%. The ex-dividend date is Friday, November 13th. Maximus’s dividend payout ratio is currently 19.50%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on MMS shares. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Finally, Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

Maximus Profile

Maximus, Inc (NYSE:MMS) is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.

Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.